<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92242">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01680354</url>
  </required_header>
  <id_info>
    <org_study_id>AUH_ASTIGMATISM</org_study_id>
    <nct_id>NCT01680354</nct_id>
  </id_info>
  <brief_title>Surgical Correction of Astigmatism</brief_title>
  <official_title>Comparative Study of Surgical Laser Correction of Astigmatism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laser correction for myopia and astigmatism using an excimer laser has been performed with
      success for several years.

      During the last 2 years, a new method for correction of refractive errors has emerged. In
      the method (ReLex) a femtosecond laser is used to cut a lenticule in the corneal stroma that
      is subsequently removed. For simple myopia this method has proved effective and on par with
      excimer baser LASIK. However, it remains to be determined if ReLEx is as effective in the
      treatment of astigmatism.

      In the study, patients with high astigmatism are treated with conventional LASIK for
      astigmatism in one eye and with ReLEx for astigmatism in the other.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Institution changed surgical method to small incision lenticule extraction. Study never
    started.
  </why_stopped>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Refraction</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>ReLEx</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One eye is treated with ReLEx the other with LASIK</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One eye is treated with ReLEx the other with LASIK</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ReLEx</intervention_name>
    <arm_group_label>ReLEx</arm_group_label>
    <other_name>Device: Carl Zeiss Meditec Visumax Femtosecond Laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK</intervention_name>
    <arm_group_label>LASIK</arm_group_label>
    <other_name>Device: Carl Zeiss Meditec MEL-80 excimer laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Myopic astigmatism between -2.0 and -5.0 diopters

          -  Maximal difference in spherical equivalent refraction of 2 D between eyes

          -  No ocular or systemic disease

          -  Not pregnant or breastfeeding

          -  Minimum BSCVA of 0.8 (decimal)

          -  Normal corneal topography

          -  Sufficient corneal thickness to allow the treatment

        Exclusion Criteria:

          -  Subjects not fulfilling the above criteria
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Ophthalmology, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>DK-8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 30, 2014</lastchanged_date>
  <firstreceived_date>September 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Anders Ivarsen</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
